(E)-2-methoxy-8-styryl-1,5-naphthyridine | 950512-59-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: (E)-2-methoxy-8-styryl-1,5-naphthyridine
• 英文别名: 2-methoxy-8-[(E)-2-phenylethenyl]-1,5-naphthyridine
• CAS: 950512-59-1
• 化学式: C₁₇H₁₄N₂O
• 分子量: 262.311
• InChiKey: KBSMXRAGKAYNAB-BQYQJAHWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  35
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (E)-2-methoxy-8-styryl-1,5-naphthyridine 在 potassium osmate(VI) dihydrate 、 sodium periodate 、 甲基磺酰胺 、 双(三甲基硅烷基)氨基钾 、 N-甲基吗啉氧化物 、 三氟乙酸 作用下， 以 四氢呋喃 、 甲醇 、 乙二醇二甲醚 、 二氯甲烷 、 水 、 乙酸乙酯 、 1,2-二氯乙烷 、 甲苯 、 叔丁醇 为溶剂， 反应 4.0h， 生成 6-({[(3S,6R)-6-[(1R,2S)-1,2-dihydroxy-2-(6-methoxy-1,5-naphthyridin-4-yl)ethyl]oxan-3-yl]amino}methyl)-2H,3H,4H-pyrido[3,2-b][1,4]thiazin-3-one
  参考文献：
  名称：

  Design, Synthesis, and Characterization of Novel Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Potent Anti-Gram-Positive Activity

  摘要：

  There is an urgent need for new antibacterial drugs that are effective against infections caused by multidrug-resistant pathogens. Novel nonfluoroquinolone inhibitors of bacterial type II topoisomerases (DNA gyrase and topoisomerase IV) have the potential to become such drugs because they display potent antibacterial activity and exhibit no target-mediated cross-resistance with fluoroquinolones. Bacterial topoisomerase inhibitors that are built on a tetrahydropyran ring linked to a bicyclic aromatic moiety through a syn-diol linker show potent anti-Gram-positive activity, covering isolates with clinically relevant resistance phenotypes. For instance, analog 49c was found to be a dual DNA gyrase topoisomerase IV inhibitor, with broad antibacterial activity and low propensity for spontaneous resistance development, but suffered from high hERG K channel block. On the other hand, analog 49e displayed lower hERG K channel block while retaining potent in vitro antibacterial activity and acceptable frequency for resistance development. Furthermore, analog 49e showed moderate clearance in rat and promising in vivo efficacy against Staphylococcus aureus in a murine infection model.

  DOI：

  10.1021/jm400963y
• 作为产物：
  描述：

  6-methoxy-1,5-naphthyridin-4-yl trifluoromethanesulfonate 、 反式-BETA-苯乙烯硼酸 在 四(三苯基膦)钯 potassium carbonate 作用下， 以 1,4-二氧六环 、 水 为溶剂， 反应 5.08h， 生成 (E)-2-methoxy-8-styryl-1,5-naphthyridine
  参考文献：
  名称：

  WO2007/107965

  摘要：

  公开号：

文献信息

• NEW BICYCLIC ANTIBIOTICS
  申请人：Actelion Pharmaceuticals Ltd.

  公开号：EP1799676A2

  公开（公告）日：2007-06-27
• TETRAHYDROPYRANE ANTIBIOTICS
  申请人：Actelion Pharmaceuticals Ltd.

  公开号：EP1981881B1

  公开（公告）日：2011-12-07
• ANTIBIOTIC COMPOUNDS
  申请人：Actelion Pharmaceuticals Ltd.

  公开号：EP1996579A2

  公开（公告）日：2008-12-03
• CYCLOHEXYL OR PIPERIDINYL CARBOXAMIDE ANTIBIOTIC DERIVATIVES
  申请人：Actelion Pharmaceuticals Ltd.

  公开号：EP2001478B1

  公开（公告）日：2010-06-02
• [EN] NEW BICYCLIC ANTIBIOTICS<br/>[FR] NOUVEAUX ANTIBIOTIQUES BICYCLIQUES
  申请人：ACTELION PERCUREX AG

  公开号：WO2006032466A2

  公开（公告）日：2006-03-30

  The invention relates to novel antibiotics of formula (I) wherein R1 represents alkyl, alkoxy, haloalkoxy, halogen or cyano; one or two of U, V, W and X represent(s) N, the remaining represent CH, or, in case of U, V and/or W, may also represent CRa and, in the case of X, may also represent CRb; Ra represents halogen; Rb represents halogen or alkoxy; M is a linking chain containing a non-aromatic cyclic or heterocyclic group, and D represents alkyl, aryl or heteroaryl.